About Apheresis Equipment
The presence of favorable government initiatives and reimbursement framework is expected to boost demand during the forecast period. The rising prevalence of blood-related disorders in developed economies is a major factor stimulating the apheresis equipment industry growth. Moreover, the growing population base in Europe is highly susceptible to various blood-related disorders such as hemophilia A, hemophilia B, thalassemia, and sickle-cell disease among others, thereby augment the huge demand for apheresis devices.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
CAGR | 9.9% |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Apheresis Equipment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Terumo BCT, Inc. (United States), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (United States), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (United States), Cerus Corporation (United States), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan) and Nikkiso Co., Ltd. (Japan) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Apheresis Equipment market by Type (Disposable Apheresis Kits and Apheresis Machines), Application (Renal Disease, Neurology and Hematology) and Region.
On the basis of geography, the market of Apheresis Equipment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Membrane filtration will boost the Apheresis Equipment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Procedure, the sub-segment i.e. Photopheresis will boost the Apheresis Equipment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technological advancements in equipment
Market Growth Drivers:
Growing prevalence of blood-related disorders and Presence of favorable reimbursement policies
Challenges:
Lack of donor availability & histocompatibility
Restraints:
Risks associated with apheresis devices
Opportunities:
Implementation of government programs in the emerging regions and Increase in the number of complex surgical procedures
Market Leaders and their expansionary development strategies
In 2021, Fresenius Kabi, a global healthcare company, announced that it will expand its single-use ingredient collection and plant facilities worth Euro 30 million in the Dominican Republic. The plant expansion will help the company maintain its position as a leading global exporter of apheresis and plasma collection equipment. and In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.
In 2021, Terumo Blood and Cell Technologies expands production capacity by opening a new USD 60 million manufacturing facility in Costa Rica. The Costa Rica plant, in addition to other products, will help expand production of the Spectra Optia Apheresis System and support its global supply chain across 130 countries., In 2021, Specializing in blood components, therapeutic apheresis, and cell technology, Terumo Blood and Cell Technologies has expanded the capabilities of Spectra Optia, therapeutic apheresis, cell processing, and cell collection platforms to an accessory device, the UVA PIT System, to provide extracorporeal light apheresis immunotherapy (ECP). ) is performed. ) procedure at the patient's bedside., In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US. and In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.
Key Target Audience
New Entrants and Investors, Apheresis Equipment Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.